Cannabis Law Report
FEBRUARY 14, 2023
The Case for Microdosing: Why Legalization Matters In a recent episode of the Third Wave Podcast, Vicente LLP founding partner Josh Kappel joined Ali Schaper, CEO and co-founder of “Into The Multiverse,” and consciousness coach Marie Mbouni M.D.
The Joint Blog
JUNE 10, 2019
percent THC in it, so it wouldn’t cause any trouble with the law. To do microdoses, you’ll want to divvy that up into five to ten doses throughout the day and figure out the best way for you to take each dose. If you have a history of issues with your kidneys or liver, you should also be wary. How Should I take my Microdose?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 19, 2022
Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. Originally Published At Microdose. Intellectual Property Due Diligence in Psychedelics.
Veriheal
MARCH 1, 2022
It may seem like a new concept to some, but there is a long history of psychedelic medicine in the United States and in the world. A Brief History Of Psychedelic Research. Albert Hoffman was said to have spent the last 25 years of his life microdosing LSD. Mr. Hoffman lived to be 102 years old, passing away in April of 2008.
Canna Law Blog
NOVEMBER 27, 2021
Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” California Psychedelic Law Update. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance.
Cannabis Law Report
JANUARY 20, 2020
Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: ‘The Therapeutic Potential Of Psychedelics Is Greater Than Cannabinoids’ Earlier this year, Canopy Growth CGC 2.31% co-founder and former CEO Bruce Linton invested in a neuropharmaceutical company, Mind Medicine Inc. . Firstly Mr Linton tells Benzinga.
Cannabis Law Report
NOVEMBER 24, 2019
Dr. Johnson recently spoke about microdosing and its affects on creativity. Dr. Griffiths will be presenting “Psilocybin: History, Neuropharmacology, and Implications for Therapeutics” at the NIMH Director’s Innovation Speaker Series. Participate in Our Studies. December 3, 2019. December 4, 2019. March 21, 2020.
Expert insights. Personalized for you.
52 
Let's personalize your content